Besides PRKAG2, mutations in genes encoding cardiac ion channels, such as FLRT3 in the TGF-β/SMAD4 signaling pathway, have also been identified in individuals with SVT [5]. This evidence concerns the gene PRKAG2 and Supraventricular tachycardia.